This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

News
27 Dec 2025

Inflagic Betamethason & Dexchlorpheniramine maleate

Recommended in the treatment of difficult cases of respiratory, dermatologic and ocular allergies, as well as ocular inflammatory disorders, where adjunctive systemic corticosteroid therapy is indicated.Representative conditions include severe fever, severe bronchial asthma, perennial allergic rhinitis, atopic dermatitis (eczema), contact dermatitis, drug reactions, and serum sickness.Inflammatory ocular disorders include allergic conjunctivitis, keratitis, non-granulomatous iritis, iridocyclitis, choroiditis, chorioretinitis, and uveitis.

CompositionBetamethason 0,25 mg/5 mlDexchlorpheniramine maleate 2 mg/5 ml

Dosage Form
Oral solution

Indication
Recommended in the treatment of difficult cases of respiratory, dermatologic and ocular allergies, as well as ocular inflammatory disorders, where adjunctive systemic corticosteroid therapy is indicated.Representative conditions include severe fever, severe bronchial asthma, perennial allergic rhinitis, atopic dermatitis (eczema), contact dermatitis, drug reactions, and serum sickness.Inflammatory ocular disorders include allergic conjunctivitis, keratitis, non-granulomatous iritis, iridocyclitis, choroiditis, chorioretinitis, and uveitis. 

Dosage Adminstration
For oral use only:- Adults and children over 12: use 1-2 ampoules/time, 2 times daily- Children 2-12 years old: use 1 ampoule/time, 1-2 times daily. Consult a doctor before use

Mentioned Companies
Ha Noi CPC1 Pharmaceutical Joint Stock Company
View company profile